Host-cell DNA methylation patterns during high-risk HPV-induced carcinogenesis reveal a heterogeneous nature of cervical pre-cancer

References

• Steenbergen RDM, Snijders PJF, Heideman DAM, et al. Clinical implications of (epi)genetic changes in HPV-induced cervical precancerous lesions. Nat Rev Cancer. 2014;14:395–405.
   PubMed Web of Science ®Google Scholar
• Wilting SM, Steenbergen RDM. Molecular events leading to HPV-induced high grade neoplasia. Papillomavirus Res. 2016;2:85–88.
   PubMed Web of Science ®Google Scholar
• Burgers WA, Blanchon L, Pradhan S, et al. Viral oncoproteins target the DNA methyltransferases. Oncogene. 2007;26:1650–1655.
   PubMed Web of Science ®Google Scholar
• Yeung CLA, Tsang WP, Tsang TY, et al. HPV-16 E6 upregulation of DNMT1 through repression of tumor suppressor p53. Oncol Rep. 2010;24:1599–1604.
   PubMed Web of Science ®Google Scholar
• Li L, Xu C, Long J, et al. E6 and E7 gene silencing results in decreased methylation of tumor suppressor genes and induces phenotype transformation of human cervical carcinoma cell lines. Oncotarget. 2015;6:23930–23943.
   PubMedGoogle Scholar
• Lorincz AT. Cancer diagnostic classifiers based on quantitative DNA methylation. Expert Rev Mol Diagn. 2014;14:293–305.
   PubMed Web of Science ®Google Scholar
• Luttmer R, De SLMA, Steenbergen RDM, et al. Management of high-risk HPV-positive women for detection of cervical (pre)cancer. Expert Rev Mol Diagn. 2016;16:961–974.
   PubMed Web of Science ®Google Scholar
• Eijsink JJH, Á L, Deregowski V, et al. A four-gene methylation marker panel as triage test in high-risk human papillomavirus positive patients. Int J Cancer. 2012;130:1861–1869.
   PubMed Web of Science ®Google Scholar
• Boers A, Wang R, van Leeuwen RW, et al. Discovery of new methylation markers to improve screening for cervical intraepithelial neoplasia grade 2/3. Clin Epigenetics. 2016;8:29.
   PubMed Web of Science ®Google Scholar
• Wang R, van Leeuwen RW, Boers A, et al. Genome-wide methylome analysis using MethylCap-seq uncovers 4 hypermethylated markers with high sensitivity for both adeno- and squamous-cell cervical carcinoma. Oncotarget. 2016;7:80735–80750.
   PubMedGoogle Scholar
• Verlaat W, Snijders PJF, Novianti PW, et al. Genome-wide DNA methylation profiling reveals methylation markers associated with 3q gain for detection of cervical precancer and cancer. Clin Cancer Res. 2017;23:3813–3822.
   PubMed Web of Science ®Google Scholar
• Steenbergen RDM, Ongenaert M, Snellenberg S, et al. Methylation-specific digital karyotyping of HPV16E6E7-expressing human keratinocytes identifies novel methylation events in cervical carcinogenesis. J Pathol. 2013;231:53–62.
   PubMed Web of Science ®Google Scholar
• Wisman GB, Nijhuis ER, Hoque MO, et al. Assessment of gene promoter hypermethylation for detection of cervical neoplasia. Int J Cancer. 2006;119:1908–1914.
   PubMed Web of Science ®Google Scholar
• Lma DS, Meijer CJLM, Berkhof J, et al. Methylation analysis of the FAM19A4 gene in cervical scrapes is highly efficient in detecting cervical carcinomas and advanced CIN2/3 lesions. Cancer Prev Res. 2014;7:1251–1257.
   PubMed Web of Science ®Google Scholar
• Steenbergen RD, Walboomers JM, Meijer CJLM, et al. Transition of human papillomavirus type 16 and 18 transfected human foreskin keratinocytes towards immortality: activation of telomerase and allele losses at 3p, 10p, 11q and/or 18q. Oncogene. 1996;13:1249–1257.
   PubMed Web of Science ®Google Scholar
• Sm W, Miok V, Jaspers A, et al. Aberrant methylation-mediated silencing of microRNAs contributes to HPV-induced anchorage independence. Oncotarget. 2016;7:43805–43819.
   PubMedGoogle Scholar
• Fe H, Sm W, Rm O, et al. Sequential gene promoter methylation during HPV-induced cervical carcinogenesis. Br J Cancer. 2007;97:1457–1464.
   PubMed Web of Science ®Google Scholar
• Mre M, Sharples KJ, Paul C, et al. Natural history of cervical neoplasia and risk of invasive cancer in women with cervical intraepithelial neoplasia 3: a retrospective cohort study. Lancet Oncol. 2008;9:425–434.
   PubMed Web of Science ®Google Scholar
• Castle PE, Schiffman M, Wheeler CM, et al. Evidence for frequent regression of cervical intraepithelial neoplasia-grade 2. Obstet Gynecol. 2009;113:18–25.
   PubMed Web of Science ®Google Scholar
• Bierkens M, Wilting SM, van Wieringen WN, et al. Chromosomal profiles of high-grade cervical intraepithelial neoplasia relate to duration of preceding high-risk human papillomavirus infection. Int J Cancer. 2012;131:579–585.
   Web of Science ®Google Scholar
• Bierkens M, Hesselink AT, Meijer CJLM, et al. CADM1 and MAL promoter methylation levels in hrHPV-positive cervical scrapes increase proportional to degree and duration of underlying cervical disease. Int J Cancer. 2013;133:1293–1300.
   PubMed Web of Science ®Google Scholar
• Holowaty P, Miller AB, Rohan T, et al. Natural history of dysplasia of the uterine cervix. J Natl Cancer Inst. 1999;91:252–258.
   PubMedGoogle Scholar
• Ostör AG. Natural history of cervical intraepithelial neoplasia: a critical review. Int J Gynecol Pathol. 1993;12:186–192.
   PubMed Web of Science ®Google Scholar
• Huisman C, Wisman GBA, Kazemier HG, et al. Functional validation of putative tumor suppressor gene C13ORF18 in cervical cancer by artificial transcription factors. Mol Oncol. 2013;7:669–679.
   PubMed Web of Science ®Google Scholar
• Huisman C, Mgp VDW, Falahi F, et al. Prolonged re-expression of the hypermethylated gene EPB41L3 using artificial transcription factors and epigenetic drugs. Epigenetics. 2015;10:384–396.
   PubMed Web of Science ®Google Scholar
• Tran YK, Bögler O, Gorse KM, et al. A novel member of the NF2/ERM/4.1 superfamily with growth suppressing properties in lung cancer. Cancer Res. 1999;59:35–43.
   PubMed Web of Science ®Google Scholar
• Gutmann DH, Donahoe J, Perry A, et al. Loss of DAL-1, a protein 4.1-related tumor suppressor, is an important early event in the pathogenesis of meningiomas. Hum Mol Genet. 2000;9:1495–1500.
   PubMed Web of Science ®Google Scholar
• Wong SY, Haack H, Kissil JL, et al. Protein 4.1B suppresses prostate cancer progression and metastasis. Proc Natl Acad Sci USA. 2007;104:12784–12789.
   PubMed Web of Science ®Google Scholar
• Dafou D, Grun B, Sinclair J, et al. Microcell-mediated chromosome transfer identifies epb41l3 as a functional suppressor of epithelial ovarian cancers. Neoplasia. 2010;12:579–589.
   PubMed Web of Science ®Google Scholar
• Snellenberg S, Cillessen SAGM, Van Criekinge W, et al. Methylation-mediated repression of PRDM14 contributes to apoptosis evasion in HPV-positive cancers. Carcinogenesis. 2014;35:2611–2618.
   PubMed Web of Science ®Google Scholar
• Lin Y-W, Tsao C-M, Yu P-N, et al. SOX1 suppresses cell growth and invasion in cervical cancer. Gynecol Oncol. 2013;131:174–181.
   PubMed Web of Science ®Google Scholar
• Tsao CM, De YM, Shih YL, et al. SOX1 functions as a tumor suppressor by antagonizing the WNT/β-catenin signaling pathway in hepatocellular carcinoma. Hepatology. 2012;56:2277–2287.
   PubMed Web of Science ®Google Scholar
• Jin Z, Mori Y, Hamilton JP, et al. Hypermethylation of the somatostatin promoter is a common, early event in human esophageal carcinogenesis. Cancer. 2008;112:43–49.
   PubMed Web of Science ®Google Scholar
• Leiszter K, Sipos F, Galamb O, et al. Promoter hypermethylation-related reduced somatostatin production promotes uncontrolled cell proliferation in colorectal cancer. PLoS One. 2015;10:e0118332.
   PubMed Web of Science ®Google Scholar
• Gan L, Chen S, Zhong J, et al. ZIC1 is downregulated through promoter hypermethylation, and functions as a tumor suppressor gene in colorectal cancer. PLoS One. 2011;6:e16916.
   PubMed Web of Science ®Google Scholar
• Qiang W, Zhao Y, Yang Q, et al. ZIC1 is a putative tumor suppressor in thyroid cancer by modulating major signaling pathways and transcription factor FOXO3a. J Clin Endocrinol Metab. 2014;99:1163–1172.
   Web of Science ®Google Scholar
• Chen Y, Zhang Z, Yang K, et al. Myeloid zinc-finger 1 (MZF-1) suppresses prostate tumor growth through enforcing ferroportin-conducted iron egress. Oncogene. 2015;34:3839–3847.
   PubMed Web of Science ®Google Scholar
• Tsai SJ, Hwang JM, Hsieh SC, et al. Overexpression of myeloid zinc finger 1 suppresses matrix metalloproteinase-2 expression and reduces invasiveness of SiHa human cervical cancer cells. Biochem Biophys Res Commun. 2012;425:462–467.
   PubMed Web of Science ®Google Scholar
• Hoque MO, Kim MS, Ostrow KL, et al. Genome-wide promoter analysis uncovers portions of the cancer methylome. Cancer Res. 2008;68:2661–2670.
   PubMed Web of Science ®Google Scholar
• De Carvalho D, Sharma S, You JS, et al. DNA methylation screening identifies driver epigenetic events of cancer cell survival. Cancer Cell. 2012;21:655–667.
   PubMed Web of Science ®Google Scholar
• Deaton A, Bird A. CpG islands and the regulation of transcription. Genes Dev. 2011;25:1010–1022.
   PubMed Web of Science ®Google Scholar
• Yang N, Eijsink JJH, Á L, et al. Methylation markers for CCNA1 and C13ORF18 are strongly associated with high-grade cervical intraepithelial neoplasia and cervical cancer in cervical scrapings. Cancer Epidemiol Biomarkers Prev. 2009;18:3000–3007.
   PubMed Web of Science ®Google Scholar
• Luttmer R, Lma DS, Berkhof J, et al. Comparing the performance of FAM19A4 methylation analysis, cytology and HPV16/18 genotyping for the detection of cervical (pre)cancer in high-risk HPV-positive women of a gynecologic outpatient population (COMETH study). Int J Cancer. 2016;138:992–1002.
   PubMed Web of Science ®Google Scholar
• Cuzick J, Bergeron C, Von Knebel Doeberitz M, et al. New technologies and procedures for cervical cancer screening. Vaccine. 2012;30:F107–F116.
   PubMed Web of Science ®Google Scholar
• Ronco G, Dillner J, Elfström KM, et al. Efficacy of HPV-based screening for prevention of invasive cervical cancer: follow-up of four European randomised controlled trials. Lancet. 2014;383:524–532.
   PubMed Web of Science ®Google Scholar
• Arbyn M, Ronco G, Anttila A, et al. Evidence regarding human papillomavirus testing in secondary prevention of cervical cancer. Vaccine. 2012;30:F88–F99.
   PubMed Web of Science ®Google Scholar
• Bergeron C, Giorgi-Rossi P, Cas F, et al. Informed cytology for triaging HPV-positive women: substudy nested in the NTCC randomized controlled trial. J Natl Cancer Inst. 2015;107:dju423.
   PubMedGoogle Scholar
• Wright TC, Stoler MH, Aslam S, et al. Knowledge of patients’ human papillomavirus status at the time of cytologic review significantly affects the performance of cervical cytology in the ATHENA study. Am J Clin Pathol. 2016;146:391–398.
   PubMed Web of Science ®Google Scholar
• Richardson LA, El-Zein M, Ramanakumar AV, et al. HPV DNA testing with cytology triage in cervical cancer screening: influence of revealing HPV infection status. Cancer Cytopathol. 2015;123:745–754.
   PubMed Web of Science ®Google Scholar
• Verhoef VMJ, Bosgraaf RP, Van Kemenade FJ, et al. Triage by methylation-marker testing versus cytology in women who test HPV-positive on self-collected cervicovaginal specimens (PROHTECT-3): A randomised controlled non-inferiority trial. Lancet Oncol. 2014;15:315–322.
   PubMed Web of Science ®Google Scholar
• Lma DS, Verhoef VMJ, Berkhof J, et al. Validation of the FAM19A4/mir124-2 DNA methylation test for both lavage- and brush-based self-samples to detect cervical (pre) cancer in HPV-positive women. Gynecol Oncol. 2016;141:341–347.
   PubMed Web of Science ®Google Scholar
• Boers A, Bosgraaf RP, van Leeuwen RW, et al. DNA methylation analysis in self-sampled brush material as a triage test in hrHPV-positive women. Br J Cancer. 2014;111:1095–1101.
   PubMed Web of Science ®Google Scholar
• Hesselink AT, Heideman DAM, Steenbergen RDM, et al. Methylation marker analysis of self-sampled cervico-vaginal lavage specimens to triage high-risk HPV-positive women for colposcopy. Int J Cancer. 2014;135:880–886.
   PubMed Web of Science ®Google Scholar
• Hesselink AT, Heideman DAM, Steenbergen RDM, et al. Combined promoter methylation analysis of CADM1 and MAL: an objective triage tool for high-risk human papillomavirus DNA-positive women. Clin Cancer Res. 2011;17:2459–2465.
   PubMed Web of Science ®Google Scholar
• Steenbergen RDM, Kramer D, Braakhuis BJM, et al. TSLC1 gene silencing in cervical cancer cell lines and cervical neoplasia. J Natl. Cancer Inst. 2004;96:294–305.
   PubMedGoogle Scholar
• Jacobs MV, Snijders PJ, Brule AJC Van Den, et al. A general primer GP5+/GP6+-mediated pcr-enzyme immunoassay method for rapid detection of 14 high-risk and 6 low-risk human papillomavirus genotypes in cervical scrapings. J Clin Microbiol. 1997;35:791–795.
   PubMed Web of Science ®Google Scholar
• Hesselink AT, Berkhof J, Van Der Salm ML, et al. Clinical validation of the HPV-risk assay, a novel real-time PCR assay for detection of high-risk human papillomavirus DNA by targeting the E7 region. J Clin Microbiol. 2014;52:890–896.
   PubMed Web of Science ®Google Scholar